Characteristic | Mean (SD) or median (Q1–Q3)/N (%) | P-value | |
---|---|---|---|
Non-antiplatelet history | mRS ≤ 2 (n = 93) | mRS > 2 (n = 70) | |
Age | 63.82 ± 12.11 | 68.71 ± 10.18 | 0.007 |
HS.CRP | 3.40 (1.27–9.36) | 4.29 (1.75–13.30) | 0.063 |
Creatinine | 71.83 ± 15.45 | 68.86 ± 19.45 | 0.279 |
Uric acid | 306.28 ± 98.39 | 310.28 ± 91.72 | 0.792 |
Platelet count | 199.08 ± 52.99 | 185.09 ± 50.81 | 0.091 |
NIHSS | 4.00 (2.00–8.00) | 10.00 (6.00–15.00) | < 0.001 |
TC | 4.31 ± 0.91 | 4.65 ± 1.69 | 0.101 |
TG | 1.22 (0.84–1.61) | 1.30 (0.96–1.56) | 0.213 |
HDLC | 1.14 (1.01–1.26) | 1.19 (1.07–1.41) | 0.124 |
LDLC | 2.53 ± 0.71 | 2.66 ± 0.70 | 0.236 |
VOLUME | 1.98 (0.39–11.23) | 6.17 (1.22–56.35) | < 0.001 |
GRASPS | 70.84 ± 6.64 | 76.07 ± 8.18 | < 0.001 |
SBP | 150.46 ± 19.72 | 150.76 ± 23.74 | 0.931 |
DBP | 85.39 ± 11.24 | 90.34 ± 20.15 | 0.048 |
FBG | 5.61 (4.76–6.75) | 6.01 (5.31–6.93) | 0.054 |
Hypertension | 0.006 | ||
 No | 42 (45.16) | 17 (24.29) |  |
 Yes | 51 (54.84) | 53 (75.71) |  |
Diabetes | 0.488 | ||
 No | 73 (78.49) | 58 (82.86) |  |
 Yes | 20 (21.51) | 12 (17.14) |  |
Coronary heart disease | 0.773 | ||
 No | 91 (97.85) | 68 (97.14) |  |
 Yes | 2 (2.15) | 2 (2.86) |  |
Stroke | 0.161 | ||
 No | 87 (93.55) | 61 (87.14) |  |
 Yes | 6 (6.45) | 9 (12.86) |  |
Gender | 0.183 | ||
 No | 23 (24.73) | 24 (34.29) |  |
 Yes | 70 (75.27) | 46 (65.71) |  |
Self-transferring | 0.083 | ||
 No | 77 (82.80) | 50 (71.43) |  |
 Yes | 16 (17.20) | 20 (28.57) |  |
ASPECTS | < 0.001 | ||
 7 | 0 (0.00) | 5 (7.14) |  |
 8 | 3 (3.23) | 3 (4.29) |  |
 9 | 14 (15.05) | 26 (37.14) |  |
 10 | 76 (81.72) | 36 (51.43) |  |
HF | 0.628 | ||
 No | 89 (95.70) | 68 (97.14) |  |
 Yes | 4 (4.30) | 2 (2.86) |  |
Smoking | |||
 No | 68 (73.12) | 46 (65.71) | 0.308 |
 Yes | 25 (26.88) | 24 (34.29) |  |